A Phase II, Open-Label, Multicenter, Multicohort Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Patients With Solid Tumors

Name: A Phase II, Open-Label, Multicenter, Multicohort Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Patients With Solid Tumors
Creator: Vivli
Published: 2025-09-17 08:47:13
License: 暂无描述

DataCite Commons2025-09-17 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00011786/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

This is a study to evaluate the efficacy, safety, and pharmacokinetics of cobimetinib plus atezolizumab in participants with advanced solid tumors including the following cohorts: squamous cell carcinoma of the head and neck (SCCHN), urothelial carcinoma (UC), and renal cell carcinoma (RCC).

提供机构：

Vivli

创建时间：

2025-09-16